Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge
- 17 November 2008
- journal article
- Published by Elsevier BV in Virology
- Vol. 383 (2), 348-361
- https://doi.org/10.1016/j.virol.2008.09.030
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- A paramyxovirus-vectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animalsVirology, 2008
- Comparative Efficacy of Neutralizing Antibodies Elicited by Recombinant Hemagglutinin Proteins from Avian H5N1 Influenza VirusJournal of Virology, 2008
- Assessment of a Vesicular Stomatitis Virus–Based Vaccine by Use of the Mouse Model of Ebola Virus Hemorrhagic FeverThe Journal of Infectious Diseases, 2007
- Successful Topical Respiratory Tract Immunization of Primates against Ebola VirusJournal of Virology, 2007
- Efficacy of Severe Acute Respiratory Syndrome Vaccine Based on a Nonhuman Primate Adenovirus in the Presence of Immunity Against Human AdenovirusHuman Gene Therapy, 2006
- A Single Intranasal Inoculation with a Paramyxovirus-Vectored Vaccine Protects Guinea Pigs against a Lethal-Dose Ebola Virus ChallengeJournal of Virology, 2006
- Infection of Ciliated Cells by Human Parainfluenza Virus Type 3 in an In Vitro Model of Human Airway EpitheliumJournal of Virology, 2005
- Neutralizing Antibodies and CD8 + T Lymphocytes both Contribute to Immunity to Adenovirus Serotype 5 Vaccine VectorsJournal of Virology, 2004
- Sorting of Marburg Virus Surface Protein and Virus Release Take Place at Opposite Surfaces of Infected Polarized Epithelial CellsJournal of Virology, 2001
- Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virusVirus Research, 1993